EyePoint Pharmaceuticals Inc (EYPT)
8.95
+0.60
(+7.19%)
USD |
NASDAQ |
Nov 22, 16:00
8.935
-0.02
(-0.17%)
After-Hours: 20:00
EyePoint Pharmaceuticals Cash from Investing (Quarterly): 16.20M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.20M |
| June 30, 2024 | -160.40M |
| March 31, 2024 | 20.81M |
| December 31, 2023 | -47.15M |
| September 30, 2023 | -1.72M |
| June 30, 2023 | 13.47M |
| March 31, 2023 | 32.09M |
| December 31, 2022 | 32.92M |
| September 30, 2022 | 6.272M |
| June 30, 2022 | -0.012M |
| March 31, 2022 | -56.44M |
| December 31, 2021 | -32.96M |
| September 30, 2021 | -0.131M |
| June 30, 2021 | -0.025M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.192M |
| September 30, 2020 | -0.128M |
| June 30, 2020 | -0.026M |
| March 31, 2020 | -0.016M |
| December 31, 2019 | -0.006M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.025M |
| March 31, 2019 | -0.182M |
| September 30, 2018 | -0.109M |
| June 30, 2018 | -1.753M |
| Date | Value |
|---|---|
| March 31, 2018 | -15.07M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.064M |
| June 30, 2017 | 2.374M |
| March 31, 2017 | 3.335M |
| December 31, 2016 | 2.388M |
| September 30, 2016 | 5.48M |
| June 30, 2016 | -5.321M |
| March 31, 2016 | 1.433M |
| December 31, 2015 | -0.028M |
| September 30, 2015 | -0.546M |
| June 30, 2015 | -0.885M |
| March 31, 2015 | -2.783M |
| December 31, 2014 | -3.058M |
| September 30, 2014 | -0.007M |
| June 30, 2014 | -0.421M |
| March 31, 2014 | -2.264M |
| December 31, 2013 | 1.309M |
| September 30, 2013 | 1.442M |
| June 30, 2013 | 2.281M |
| March 31, 2013 | 0.56M |
| December 31, 2012 | 2.87M |
| September 30, 2012 | 0.647M |
| June 30, 2012 | 0.091M |
| March 31, 2012 | 0.108M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-160.40M
Minimum
Jun 2024
32.92M
Maximum
Dec 2022
-8.873M
Average
-0.0205M
Median
Cash from Investing (Quarterly) Benchmarks
| Cassava Sciences Inc | -0.017M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Adverum Biotechnologies Inc | -13.35M |
| Regenxbio Inc | 50.26M |
| Editas Medicine Inc | 83.98M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.03M |
| Cash from Financing (Quarterly) | 11.89M |
| Free Cash Flow | -118.04M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -40.60M |
| Free Cash Flow Yield | -26.02% |